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Background
Both particulate (pGC) and soluble guanylyl cyclases
(sGC) synthesize cGMP. While sGC is activated by nitric
oxide (NO), pGC is activated by natriuretic peptides
(NPs) such as ANP or BNP. Physiological effects of cGMP
are mainly mediated by cGMP-dependent protein kinase
(PKG) and cGMP phosphodiesterases (PDEs), namely
PDE2 and PDE5. We hypothesised that PKG may underlie
regulatory feedback in cGMP signals produced by pGC
and sGC activation in adult rat ventricular myocytes
(ARVMs).
Materials and methods
To test this hypothesis, subsarcolemmal cGMP signals
elicited by NO-donors or NPs in the presence of the PKG
inhibitor, KT5823 (KT, 50 nM) were monitored in
ARVMs. Myocytes were infected by an adenovirus express-
ing the WT rat olfactory cyclic nucleotide-gated channel
CNGA2 and the cGMP-gated current (ICNG) was recorded
by the whole-cell patch-clamp technique.
Results
Application of the membrane permeant cGMP analog Sp-
8-pCPT-cGMPS (Sp-8, 100 μM) induced a large ICNG cur-
rent in myocytes infected by CNGA2 adenovirus, but not
in control cells. KT increased 3-fold the ICNG current fol-
lowed by activation of sGC by S-nitroso-N-acetyl-peni-
cillamine (SNAP, 100 μM). This effect was abolished in
the presence of the non selective PDE inhibitor IBMX
(100 μM) or a selective PDE5 inhibitor (sildenafil, 100
nM). Surprisingly, KT decreased (by 50%) the ICNG current
stimulated by ANP (10 nM and 100 nM) in a PDE-inde-
pendent manner, but had no effect on total cGMP content
measured by radioimmunoassay, which is controlled by
PDE2 and PDE5 subtypes.
Conclusion
Our results suggest that in ARVMs the subsarcolemmal
cGMP pools generated by sGC or pGC are differentially
regulated by PKG. In the sGC pool, PDE5 mediates the
effects of PKG, while in the pGC pool, the PKG effect is
independent of PDE activity. These differential regula-
tions of cGMP signals may underlie the specific effects of
NPs and NO-donors on cardiac function.
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